ClearPoint Neuro Officer Joseph Burnett Files Intent to Sell $800K in Shares
CLPT has more than doubled off its 52-week low of $8.27 on elevated volume (10× avg).
Summary
ClearPoint Neuro officer Joseph Burnett has filed a Form 144, indicating his intent to sell 60,000 shares valued at approximately $800,400. These shares were acquired through the exercise of stock options.
Key Events · Ownership and Investor Activity · CLPT
-
Officer Files Intent to Sell Shares
Joseph Burnett, an officer and director of ClearPoint Neuro, Inc., has filed a Form 144 indicating his intent to sell 60,000 common shares.
-
Proposed Sale Value
The shares intended for sale have an approximate market value of $800,400.00.
-
Shares Acquired via Option Exercise
The shares to be sold were acquired on June 17, 2026, through the exercise of stock options, with payment made in cash.
-
Part of Broader Insider Selling Trend
This filing is part of an ongoing pattern of Form 144 filings by insiders at ClearPoint Neuro, with 4 such filings in the last 90 days, contributing to a net insider distribution of over $308,000 in open-market sales.
Analysis · CLPT · Industrial Applications And Services
This Form 144 indicates an officer's intent to sell a substantial amount of shares, valued at over $800,000. While the shares were acquired through option exercise, the immediate intent to sell still represents a reduction in direct equity exposure by a key insider. This transaction contributes to a recent pattern of insider sales at ClearPoint Neuro, which could be interpreted as a lack of conviction or a move to monetize compensation.
At the time of this filing, CLPT was trading at $17.01 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $504.1M. The 52-week trading range was $8.27 to $30.10. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.